Indeed, we found that transfection with FXR siRNA and treatment with GS resulted in a marked reduction in cell proliferation, migration, and invasion, suggesting that FXR expression promote tumour progression in pancreatic cancer. This evidence concerns the gene NR1H4 and familial pancreatic carcinoma.